Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
The Genome Institute of Singapore (GIS) invites applications for an AI Scientist – Generative AI Models for the Creation of RNA-Based Drugs. Join the Laboratory of AI in Genomics in Singapore to develop next‑generation AI models for mRNA design and evaluation in a cutting-edge, collaborative setting.
The postdoctoral researcher will build generative AI models for mRNA optimisation, run large‑scale pretraining on HPC, and apply supervised fine‑tuning and reinforcement learning to advance RNA
AI Scientist – Generative AI Models for the Creation of RNA-Based Drugs
The Genome Institute of Singapore (GIS) is the national flagship for genomic sciences, driving cutting-edge research at the intersection of biology, engineering, and medicine. This position is offered in the Laboratory of AI in Genomics, led by Prof. Mile Šikić, which uses advanced bioinformatics and deep learning approaches to develop next-generation models for genomic data analysis. We are a group of computer scientists with a mission to improve healthcare using advanced deep learning models. Located in the heart of Singapore’s thriving biomedical hub, GIS offers a dynamic and collaborative environment, with close ties to world-class universities (NUS and NTU), pharmaceutical companies, and biotech start-ups. Joining our team means working on transformative projects with real-world impact, while benefiting from Singapore’s vibrant research ecosystem and strong support for innovation.
Messenger RNA (mRNA)-based therapeutics, including vaccines, represent a transformative class of drugs for infectious diseases and cancer immunotherapy. Their programmable nature allows rapid adaptation to evolving pathogens and personalized medicine, but effective design of mRNA molecules remains a key bottleneck. Current development relies on trial-and-error methods, leading to long timelines, high costs, and suboptimal outcomes.
This project aims to develop an agent-based generative AI system to design both linear and circular mRNA molecules. By unifying the design process into a data-driven, adaptive pipeline, the system will optimise vaccine stability, minimise unwanted immune responses, and accelerate early-stage research and development from months to hours. The outcome will be a robust, scalable platform for creating effective mRNA vaccines and drugs for infectious diseases, cancer, and beyond.
We are looking for a highly motivated postdoctoral researcher to:
We welcome applications from candidates with: